MycoBiomDB – Record Details (MyCo_2395)

Biomarker Record Details

Database ID: MyCo_2395
DB IDMyCo_2395
TitleThe utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis
Year2013
PMID23632100
Fungal Diseases involvedPulmonary aspergillosis
DiseaseAspergillosis (Aspergillus Infection)
Associated Medical ConditionNone
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementThis study was approved by the ethics committee of Tokyo Medical University.
Site of InfectionUnspecified
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomannan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationJapan
CohortPatients at Tokyo Medical University Hospital who were clinically suspected to have pulmonary aspergillosis be- tween April 2008 and October 2011 were enrolled in this study. During the study period, the GM antigens in the serum and BW were assessed in 45 patients.
Cohort No.45
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
Sub TechniqueELISA
TechniqueImmunoassay
Analysis MethodELISA Based
ELISA kitsELISA Kit- Platelia Aspergillus (Bio-Rad Laboratories, Hercules, CA, USA)
Assay DataNone
Validation Techniques usedFDA Approved -Platelia Aspergillus Ag ELISA
Up Regulation Down RegulationPositive
Sequence DataNone